Evidence map

ArticleThe New England journal of medicine2022

Tirzepatide versus Semaglutide Once Weekly in Type 2 Diabetes.

Dimitrios Patoulias et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2022
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35172065